Breaking News Instant updates and real-time market news.

TRIB

Trinity Biotech

$6.43

-0.05 (-0.77%)

13:15
10/16/16
10/16
13:15
10/16/16
13:15

Trinity Biotech investors should look elsewhere, Barron's says

Trinity Biotech, which plunged recently after withdrawing the regulatory application seeking approval for its heart attack test, is cheap, but confidence in the company's management has "taken a tremendous blow" and investors can "probably do better" elsewhere, Barron's contends in a 'Sizing Up Small Caps' column. Reference Link

  • 25

    Oct

TRIB Trinity Biotech
$6.43

-0.05 (-0.77%)

04/21/16
ROTH
04/21/16
NO CHANGE
Target $13
ROTH
Buy
Roth Capital remains bullish on long-term Trinity Biotech troponin opportunity
Roth Capital analyst Chris Lewis remains bullish on the long-term Trinity Biotech's troponin opportunity, after the company received the FDA's formal response for its troponin 510k submission, which does not request any extensive additional data. However, the analyst looks for improved underlying growth and profitability trends to materialize to gain higher near-term conviction on the name. Lewis reiterates a Buy rating and $13 price target on the shares.
10/05/16
SPHN
10/05/16
DOWNGRADE
SPHN
Equal Weight
Trinity Biotech downgraded to Equal Weight from Overweight at Stephens
10/05/16
10/05/16
DOWNGRADE
Target $7

Equal Weight
Trinity Biotech downgraded to Equal Weight at Stephens
As previously reported, Stephens analyst Drew Jones downgraded Trinity Biotech to Equal Weight from Overweight following the announcement of the withdrawal of Meritas Troponin test from FDA consideration. While the company is not abandoning the Meritas technology, the analyst notes that he currently has limited visibility into how the program will be progressed. Jones also remains conservative with expectations of Trinity Biotech successfully turning into an EPS growth story. He lowered his price target on the shares to $7 from $22.
10/05/16
10/05/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Barrick Gold (ABX) downgraded to Buy from Conviction Buy at Goldman with analyst Andrew Quail citing increased macro headwinds negatively impacting gold prices. 2. Norwegian Cruise Line (NCLH) downgraded to Neutral from Buy at UBS. 3. Gigamon (GIMO) downgraded to Market Perform from Outperform at Raymond James and to Neutral from Buy at DA Davidson. 4. iRadimed (IRMD) downgraded to Neutral from Buy at Roth Capital. 5. Trinity Biotech (TRIB) downgraded to Equal Weight from Overweight at Stephens with analyst Drew Jones citing the announcement of the withdrawal of Meritas Troponin test from FDA consideration. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DDAIF

Daimler AG

$78.84

-0.86 (-1.08%)

, TSLA

Tesla

$344.99

-6.1 (-1.74%)

08:44
09/26/17
09/26
08:44
09/26/17
08:44
Periodicals
Daimler responds to Elon Musk tweet on electric vehicles, TechCrunch says »

Daimler (DDAIF) announced…

DDAIF

Daimler AG

$78.84

-0.86 (-1.08%)

TSLA

Tesla

$344.99

-6.1 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

DVCR

Diversicare

$11.10

0.1 (0.91%)

, OHI

Omega Healthcare

$32.45

0.36 (1.12%)

08:43
09/26/17
09/26
08:43
09/26/17
08:43
Hot Stocks
Diversicare, Omega Healthcare agree to terms of new master lease »

Diversicare Healthcare…

DVCR

Diversicare

$11.10

0.1 (0.91%)

OHI

Omega Healthcare

$32.45

0.36 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

08:43
09/26/17
09/26
08:43
09/26/17
08:43
Hot Stocks
Darden says expects impact of Hurricane Irma to be double that of Harvey »

Says Irma impact factored…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMRS

Amyris

$3.21

-0.29 (-8.29%)

08:42
09/26/17
09/26
08:42
09/26/17
08:42
Hot Stocks
Amyris enters second product development, production agreement with Royal DSM »

Amyris announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTR

Ventas

$66.62

0.58 (0.88%)

08:42
09/26/17
09/26
08:42
09/26/17
08:42
Conference/Events
The Executives' Club of Chicago holds a luncheon meeting »

The Executives' Club…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

08:40
09/26/17
09/26
08:40
09/26/17
08:40
General news
U.S. equities are mostly mildly firmer »

U.S. equities are mostly…

08:40
09/26/17
09/26
08:40
09/26/17
08:40
General news
Breaking General news story  »

Week of 9/23 Redbook to…

DRI

Darden

$83.14

0.26 (0.31%)

08:39
09/26/17
09/26
08:39
09/26/17
08:39
Hot Stocks
Breaking Hot Stocks news story on Darden »

Darden says Hurricane…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NVDA

Nvidia

08:38
09/26/17
09/26
08:38
09/26/17
08:38
Technical Analysis
Technical View: Nvidia bounces back from prior session losses »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCYT

Veracyte

$8.49

0.01 (0.12%)

08:38
09/26/17
09/26
08:38
09/26/17
08:38
Recommendations
Veracyte analyst commentary  »

Veracyte visibility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

08:36
09/26/17
09/26
08:36
09/26/17
08:36
Hot Stocks
Darden says all businesses 'remain strong' »

Says to-go sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TEUM

Pareteum

$1.06

0.01 (0.95%)

08:35
09/26/17
09/26
08:35
09/26/17
08:35
Hot Stocks
Breaking Hot Stocks news story on Pareteum »

Pareteum Corp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVEE

NV5 Global

$53.85

2.15 (4.16%)

08:34
09/26/17
09/26
08:34
09/26/17
08:34
Hot Stocks
NV5 Global awarded $14M program management contract by Merced County »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

CSBR

Champions Oncology

$3.66

-0.09 (-2.40%)

08:33
09/26/17
09/26
08:33
09/26/17
08:33
Hot Stocks
Champions Oncology awarded $2M from National Cancer Institute »

Champions Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.96

0.03 (1.55%)

, UNIT

Uniti Group

$17.36

0.85 (5.15%)

08:33
09/26/17
09/26
08:33
09/26/17
08:33
Hot Stocks
Windstream says allegations in purported notice of default 'without merit' »

In a regulatory filing…

WIN

Windstream

$1.96

0.03 (1.55%)

UNIT

Uniti Group

$17.36

0.85 (5.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

OSIS

OSI Systems

$85.81

-1.08 (-1.24%)

08:32
09/26/17
09/26
08:32
09/26/17
08:32
Hot Stocks
OSI Systems receives $16M in orders for ETD systems »

OSI Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Oct

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

08:32
09/26/17
09/26
08:32
09/26/17
08:32
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant says Mindset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

GILD

Gilead

$83.61

0.34 (0.41%)

, KITE

Kite Pharma

$179.31

0.01 (0.01%)

08:31
09/26/17
09/26
08:31
09/26/17
08:31
Hot Stocks
Gilead, Kite Pharma announce expiration of HSR waiting period »

Gilead Sciences (GILD)…

GILD

Gilead

$83.61

0.34 (0.41%)

KITE

Kite Pharma

$179.31

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 12

    Feb

08:31
09/26/17
09/26
08:31
09/26/17
08:31
Conference/Events
Federal Reserve Bank of Atlanta President speaks on the economic outlook »

Atlanta Federal Reserve…

CAB

Cabela's

$61.50

0.03 (0.05%)

, SHOR

ShoreTel

08:30
09/26/17
09/26
08:30
09/26/17
08:30
Options
Two option delistings on September 26th »

Option delistings…

CAB

Cabela's

$61.50

0.03 (0.05%)

SHOR

ShoreTel

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:30
09/26/17
09/26
08:30
09/26/17
08:30
General news
U.S. Case-Shiller home prices preview: »

U.S. Case-Shiller home…

MSFT

Microsoft

$73.26

-1.15 (-1.55%)

08:29
09/26/17
09/26
08:29
09/26/17
08:29
Recommendations
Microsoft analyst commentary  »

Valuing Microsoft should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 22

    Oct

08:29
09/26/17
09/26
08:29
09/26/17
08:29
Conference/Events
House Homeland Security Committee to hold a hearing »

The Oversight and…

SNX

Synnex

$116.50

0.4 (0.34%)

08:28
09/26/17
09/26
08:28
09/26/17
08:28
Recommendations
Synnex analyst commentary  »

Synnex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

08:28
09/26/17
09/26
08:28
09/26/17
08:28
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.